Your session is about to expire
← Back to Search
Treatment for Coronavirus (MFMU COVID-19 Trial)
N/A
Waitlist Available
Research Sponsored by The George Washington University Biostatistics Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up delivery through hospital discharge up to 120 days
Awards & highlights
Summary
A cohort study of women who deliver at select sites on randomly selected days in 2019 and 2020, and all confirmed COVID-19 infections among pregnant or immediately postpartum women in 2020. The study population includes approximately 24,400 deliveries on randomly selected days in 2019 and 2020, and an additional 1000-2100 confirmed COVID-19 infections among pregnant women or immediately postpartum.
Eligible Conditions
- Coronavirus
- Pregnancy Complications
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ delivery through hospital discharge up to 120 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~delivery through hospital discharge up to 120 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Maternal Mortality and Morbidity Composite
Secondary study objectives
Adverse maternal outcomes
Adverse neonatal outcomes
Cesarean Delivery
+7 moreFind a Location
Who is running the clinical trial?
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,014 Previous Clinical Trials
2,671,230 Total Patients Enrolled
The George Washington University Biostatistics CenterLead Sponsor
25 Previous Clinical Trials
77,728 Total Patients Enrolled
Andrew Bremer, MD, PhD, MASStudy DirectorEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
4 Previous Clinical Trials
18,071 Total Patients Enrolled
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger